Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P72
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gargosky, Sharron
Team, Canvas Clinical
Article History
First Online: 6 November 2014